Cargando…

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

Detalles Bibliográficos
Autores principales: Gregory, Gareth P., Dickinson, Michael, Yannakou, Costas K., Wong, Jonathan, Blombery, Piers, Corboy, Greg, Kats, Lev, Crozier, Tim M.E., Kumar, Beena, Prince, H. Miles, Opat, Stephen S., Shortt, Jake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746031/
https://www.ncbi.nlm.nih.gov/pubmed/31723826
http://dx.doi.org/10.1097/HS9.0000000000000187
_version_ 1783451643608563712
author Gregory, Gareth P.
Dickinson, Michael
Yannakou, Costas K.
Wong, Jonathan
Blombery, Piers
Corboy, Greg
Kats, Lev
Crozier, Tim M.E.
Kumar, Beena
Prince, H. Miles
Opat, Stephen S.
Shortt, Jake
author_facet Gregory, Gareth P.
Dickinson, Michael
Yannakou, Costas K.
Wong, Jonathan
Blombery, Piers
Corboy, Greg
Kats, Lev
Crozier, Tim M.E.
Kumar, Beena
Prince, H. Miles
Opat, Stephen S.
Shortt, Jake
author_sort Gregory, Gareth P.
collection PubMed
description
format Online
Article
Text
id pubmed-6746031
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67460312019-11-13 Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS Gregory, Gareth P. Dickinson, Michael Yannakou, Costas K. Wong, Jonathan Blombery, Piers Corboy, Greg Kats, Lev Crozier, Tim M.E. Kumar, Beena Prince, H. Miles Opat, Stephen S. Shortt, Jake Hemasphere Case Report Wolters Kluwer Health 2019-03-01 /pmc/articles/PMC6746031/ /pubmed/31723826 http://dx.doi.org/10.1097/HS9.0000000000000187 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Case Report
Gregory, Gareth P.
Dickinson, Michael
Yannakou, Costas K.
Wong, Jonathan
Blombery, Piers
Corboy, Greg
Kats, Lev
Crozier, Tim M.E.
Kumar, Beena
Prince, H. Miles
Opat, Stephen S.
Shortt, Jake
Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title_full Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title_fullStr Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title_full_unstemmed Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title_short Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
title_sort rapid and durable complete remission of refractory aitl with azacitidine treatment in absence of tet2 mutation or concurrent mds
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746031/
https://www.ncbi.nlm.nih.gov/pubmed/31723826
http://dx.doi.org/10.1097/HS9.0000000000000187
work_keys_str_mv AT gregorygarethp rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT dickinsonmichael rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT yannakoucostask rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT wongjonathan rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT blomberypiers rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT corboygreg rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT katslev rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT croziertimme rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT kumarbeena rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT princehmiles rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT opatstephens rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds
AT shorttjake rapidanddurablecompleteremissionofrefractoryaitlwithazacitidinetreatmentinabsenceoftet2mutationorconcurrentmds